Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity. (Q47950160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

title

Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

0 references

0 references

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

author name string

F J Meye

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

V Trezza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

G M J Ramakers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

R A H Adan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

16 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1294-1301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23070073 AND SRC:MED&resulttype=core&format=json

Inflammation and metabolic disorders

15 February 2020

cites work

1 reference

Food reward, hyperphagia, and obesity

21 January 2018

1 reference

Anti-obesity drugs and neural circuits of feeding.

21 January 2018

1 reference

Pharmacological management of appetite expression in obesity

21 January 2018

1 reference

Lifestyle modification for the management of obesity

21 January 2018

1 reference

The future of endocannabinoid-oriented clinical research after CB1 antagonists.

21 January 2018

1 reference

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation

21 January 2018

1 reference

Endocannabinoid control of food intake and energy balance

21 January 2018

1 reference

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

21 January 2018

1 reference

Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists

21 January 2018

1 reference

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial

21 January 2018

1 reference

Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors

21 January 2018

1 reference

Inverse agonism and neutral antagonism at cannabinoid CB1 receptors

21 January 2018

1 reference

The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats

21 January 2018

1 reference

Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions

21 January 2018

1 reference

Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.

21 January 2018

1 reference

Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor

21 January 2018

1 reference

Modulation of ATP-mediated contractions of the rat vas deferens through presynaptic cannabinoid receptors.

21 January 2018

1 reference

The role of dopamine in the pathophysiology of depression

21 January 2018

1 reference

The mesolimbic dopamine reward circuit in depression

21 January 2018

1 reference

Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety

21 January 2018

1 reference

Amygdala circuitry mediating reversible and bidirectional control of anxiety

21 January 2018

1 reference

Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety

21 January 2018

1 reference

Presynaptic metabotropic glutamate receptors regulate glutamatergic input to dopamine neurons in the ventral tegmental area

21 January 2018

1 reference

Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.

21 January 2018

1 reference

Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms.

21 January 2018

1 reference

Postsynaptic mechanism of depression of GABAergic synapses by oxytocin in the supraoptic nucleus of immature rat.

21 January 2018

1 reference

Mapping of chemical trigger zones for reward

21 January 2018

1 reference

Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies

21 January 2018

1 reference

Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement

21 January 2018

1 reference

Reconsidering anhedonia in depression: lessons from translational neuroscience

21 January 2018

1 reference

Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.

21 January 2018

1 reference

Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids

21 January 2018

1 reference

Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers

21 January 2018

1 reference

Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists

21 January 2018

1 reference

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus

21 January 2018

1 reference

The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction

21 January 2018

1 reference

Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.

21 January 2018

1 reference

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

The hope and fear of rimonabant

21 January 2018

1 reference

Localization of Dysfunction in Major Depressive Disorder: Prefrontal Cortex and Amygdala

21 January 2018

1 reference

The endogenous cannabinoid system controls extinction of aversive memories

21 January 2018

1 reference

A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions

21 January 2018

1 reference

Diagnosing major depressive disorder VIII: are some symptoms better than others?

21 January 2018

1 reference

The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats

21 January 2018

1 reference

Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids.

21 January 2018

1 reference

Feeding induced by cannabinoids is mediated independently of the melanocortin system

21 January 2018

1 reference

SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2 currents by reversal of tonic CB1 cannabinoid receptor activity

21 January 2018

1 reference